Christopher D. Hillyer, MD, President and CEO of New York Blood Center (NYBC), and Professor, Department of Medicine, Weill Cornell Medical College in New York, was previously the endowed Distinguished Service Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, where he served as director of the Emory Center for Transfusion and Cellular Therapies. He is board certified in transfusion medicine, hematology, medical oncology and internal medicine. Dr. Hillyer received his BS from Trinity College and his MD from the University of Rochester School of Medicine, with postgraduate fellowships in hematology-oncology, transfusion medicine and bone marrow transplantation at Tufts-New England Medical Center in Boston. He is an editor of 12 textbooks including the 16-18th editions of the AABB Technical Manual, and is recognized internationally as an expert in hematology, blood transfusion, and cellular therapies. His book, Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects, has become a primary resource throughout the world.
Dr. Hillyer has authored more than 150 articles pertaining to transfusion, human immunodeficiency virus, and herpes viruses, most notably CMV, has been awarded millions of dollars in research funding from the National Institutes of Health, the CDC, and other agencies. He is a past-president of AABB, a former trustee of the National Blood Foundation, and serves as an associate editor of TRANSFUSION.
In 2014, Dr. Hillyer received the Emily Cooley Award for his “significant commitment and contributions to the field of transfusion medicine..." He was previously recognized with two Tiffany Awards from the American Red Cross for his work in Africa. Dr. Hillyer is an architect of NYBC Ventures, co-founder of Transfusion & Transplantation Technologies, Inc. (3Ti), HemeXcel Purchasing Alliance, and HemeXcel Resources, and holds a number of patents related to blood banking and cellular therapies.